Misael Medina MD
@misamed
Interventional and Structural Cardiologist - CHIP & CTO Fan 🇲🇽
ID: 89561581
http://www.gdlcardiologia.com 12-11-2009 22:45:36
2,2K Tweet
742 Takipçi
565 Takip Edilen
A 57 y/o male became the 1st patient in the world to receive a genetically modified porcine cardiac #xenotransplantation at University of Maryland School of Medicine. Given the novelty of the procedure, monitoring the transplant for xenograft function proved difficult. bit.ly/3tWTdfm #JACCEdge
Final MITRAL Trial 5Y outcomes LBCT @ #EuroPCR 2023. MViV, MViR & ViMAC with Sapien 3 was associated with sustained improvement of HF symptoms & QoL @ 5 years. THV function remained stable in all groups. Excellent survival @ 5 years in MViV, lower in MViR & ViMAC. Mayo Clinic CV
Great meeting with friends and colleagues from Mexico and LATAM! José Alfredo Merino Rajme Marco Alcantara ROBERTO MURATALLA MD Luis Marroquin ALEJANDRO ALCOCER CH Edwards TAVR TAVR Bot
Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now? recintervcardiol.org/en/editorial/t… #recintervcardiol vía REC Publications Juan Pablo Sánchez-Luna TAVR Bot PCRonline 🫀 EuroIntervention Soc Esp Cardiología ACI-SEC: Hemodinamica
👉TricValve outcomes at 1yr FU in JACC Journals demonstrates clear ⬆️in QoL & ⬇️mortality authors.elsevier.com/a/1iD0L6uPJvqi… Sara Blasco Turrión Kasparas Briedis Rodrigo Estévez Angel Schez-Recalde Ignacio Cruz Gonzalez Isaac Pascual Julia Mascherbauer Manuel Pan Ramiro Trillo Raul Moreno Soc Esp Cardiología
The LANDMARK trial demonstrated that the Myval transcatheter heart valve (THV) series is non-inferior to both the SAPIEN and Evolut THV series in terms of safety and effectiveness at 30 days. #EAPCI Niels van Royen Read more: ow.ly/Obqv50UK47x
